Export and Other Restrictions. This Agreement and obligations of the Parties hereunder are made subject to, and limited by, all applicable restrictions concerning the export of products, resources, materials or technologies from the People’s Republic of China (“PRC” or “China”, for the purpose of this Agreement excluding Hong Kong, Macau and Taiwan) which may be imposed upon or related to Zai Lab or GSK from time to time by the government of PRC. Zai Lab acknowledges and agrees that the Transferred Know-How, Licensed Patents and/or Inventory contains traditional Chinese medicine substance and technologies which have been disclosed to Zai Lab prior to the Effective Date, and GSK will deliver all such Inventory and conduct Technology Transfer to the extent within the territory of PRC to Zai Lab. Zai Lab shall be solely responsible for the risk of export restrictions (if any) to any Compounds, Products, Inventory, Transferred Know-How and Licensed Patents, as well as the application and/or registration in respect of export of such products, resources, materials or technologies.

“Sanctions and Export Control Laws” means all U.S. and non-U.S. laws, statutes, measures, orders, and regulations relating to # economic or trade sanctions administered or enforced by the United States (including by the U.S. Department of Treasury Office of Foreign Assets Control (“OFAC”), the U.S. Department of State, and the U.S. Department of Commerce, or any other relevant Governmental Authority; and # export, import, deemed export, transfer, and retransfer controls, including the U.S. Export Administration Regulations and the U.S. Export Control Reform Act of 2018.

To assure compliance with the export control Laws and regulations of the United States government, specifically the U. S. Department of Energy export regulations of nuclear technology under 10 C.F.R. Part 810, the U.S. Nuclear Regulatory Commission export and import regulations related to nuclear equipment and material under 10 C.F.R. Part 110, and the U.S. Department of Commerce export regulations of commercial or dual-use technology under 15 C.F.R. Part 730 et seq. concerning the export of technical data or similar information to specific countries, locations, or entities, a Party shall not disclose or permit the disclosure, transfer or re-export, directly or indirectly, of any Confidential and Proprietary Information it receives hereunder that a receiving Party considers to be potentially subject to U.S. export control, or any product or technical data derived from such Confidential and Proprietary Information, except in compliance with such export control laws and regulations, which may be contingent on additional United States Governmental Approvals.

The Company is currently in compliance with, and has complied with, all Export Control Laws applicable to it. Without limiting the foregoing: # the Company has obtained all material export licenses and

other material approvals required for its exports of products required by any Export Control Law and all such approvals and licenses are in full force and effect; # the Company is in compliance with the terms of such applicable export licenses or other approvals; and # there are no claims pending or threatened in writing against the Company with respect to such export licenses or other approvals.

“EAR” means the U.S. Export Administration Regulations.

the right to market Natural Gas, including purchase of the Government’s and/or its designee’s share, to the highest value outlets (domestic or export) and the right to export the Parties’ Entitlements of Natural Gas;

Neuren not to sell or export Product in Territory

“EXIM Bank” means Export-Import Bank of the United States.

“EXIM Eligible Receivables” means Eligible Export-Related Accounts Receivable as defined in the [[Organization A:Organization]] Agreement.